App-assisted Medical Nutrition Therapy for diabetes with insulin use
Official title: APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
Run by Weill Medical College of Cornell University · NCT07773779 · Data updated 2026-11-12
This study tests whether using the Undermyfork Care app together with nutrition counseling improves blood sugar, cholesterol, quality of life, activity, and eating choices in adults with type 1 or type 2 diabetes who use insulin.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | July 29, 2026 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT07773779 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-75 with type 1 or type 2 diabetes requiring insulin, an A1C ≥ 6.5%, a compatible smartphone, and active Dexcom CGM use.
✕Probably not a fit
People not using a Dexcom CGM, those without smartphone access, or with exclusionary conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this interventional study, adults with insulin-requiring diabetes will use the Undermyfork Care app alongside nutrition counseling from a registered dietitian. Participants will be evaluated on glycemic control, lipid levels, quality of life, physical activity, and dietary habits. The trial compares app-supported care to usual care to see if digital tools can enhance standard medical nutrition therapy. Eligible participants must have a compatible smartphone, a Dexcom CGM in use, and an A1C of 6.5% or higher. The study is led by Weill Medical College of Cornell University with collaborators from West Chester University and the Academy of Nutrition and Dietetics and will take place at Weill Cornell Medicine in New York.</medium_description>
Why it matters
Potential benefit: If successful, participants could see better blood sugar control and cholesterol, along with improved quality of life and healthier eating patterns.
How similar studies have gone: Prior studies suggest that digital nutrition tools can support diabetes management when paired with clinician guidance, but results vary by population and app features.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female 18-75 years of age. * Documentation of a T1D or T2D diagnosis. * A1C of 6.5 or greater. * Access to a compatible smartphone. * Using a Dexcom continuous glucose monitoring device (due to compatibility with Undermyfork app) for at least 1 month with an active time of at least 70% within the last 14 days. Exclusion Criteria: * Heart failure. * Advanced kidney disease. * Severe cognitive or psychological disabilities. * Depression. * Pregnant or breastfeeding.
Where it's running
-
Weill Cornell Medicine
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Rachel Salzman — Weill Medical College of Cornell University
- Study coordinator: Patricia Davidson, DCN
- Email: pdavidson@wcupa.edu
- Phone: 610-436-1066
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Dexcom G7 CGM in critically ill adults after major abdominal surgery or solid organ transplant
This study tests how accurately the Dexcom G7 continuous glucose monitor tracks glucose in ICU patients after major abdominal surgery or solid organ transplantation who need tight insulin control.
-
Three-stage CGM integration program for older adults with insulin-dependent diabetes
A program with three CGM-focused training sessions is being tested to see if it helps older adults using insulin wear CGMs more and manage their glucose better compared with standard CGM training.
-
Mobile AI app to predict glucose and suggest insulin bolus doses for people on multiple daily injections
This study will test whether a smartphone AI app can help adults with insulin-requiring diabetes on multiple daily injections predict blood sugar and suggest bolus doses to increase time-in-range and reduce highs and lows.
-
MiniMed NMX8 automated insulin delivery system vs 780G in people with diabetes
This study tests whether the new MiniMed NMX8 automated insulin delivery system works safely and performs as well as or better than the existing 780G system in people with insulin-requiring diabetes.
-
Using ultrasound to prevent insulin-related fatty lumps in people with diabetes
This project will try using ultrasound scans in diabetes clinics to find hidden insulin-related fatty lumps (lipohypertrophy) in adults on insulin who use CGM and have variable glucose levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.